NO20051497L - Beta-laktamaseinhibitorprodrug. - Google Patents

Beta-laktamaseinhibitorprodrug.

Info

Publication number
NO20051497L
NO20051497L NO20051497A NO20051497A NO20051497L NO 20051497 L NO20051497 L NO 20051497L NO 20051497 A NO20051497 A NO 20051497A NO 20051497 A NO20051497 A NO 20051497A NO 20051497 L NO20051497 L NO 20051497L
Authority
NO
Norway
Prior art keywords
lactam antibiotic
prodrug
solvate
mammal
administering
Prior art date
Application number
NO20051497A
Other languages
English (en)
Other versions
NO20051497D0 (no
Inventor
Anthony Marfat
Dale Gordon Mcleod
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20051497L publication Critical patent/NO20051497L/no
Publication of NO20051497D0 publication Critical patent/NO20051497D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Prodrug av 6-P-hydroksymetylpenicillansyresulfon som har strukturen hvori R er H eller metyl og solvater derav er beskrevet. Også beskrevet er farmasøytiske sammensetninger som irmbefatter et prodrug ifølge oppfirmelsen, eller et solvat derav, et eventuelt P-laktamantibiotisk middel og minst en farmasøytisk akseptabel bærer. Videre er det beskrevet en fremgangsmåte for å øke den terapeutiske effektiviteten til et P-laktamantibiotisk middel hos et pattedyr ved å administtere en effektiv mengde av et P-laktamantibiotisk middel og en effektivitetsøkende mengde av et prodrug ifølge oppfirmelsen, eller et solvat derav. Ytterligere beskrevet er en fremgangsmåte for behandling av en bakteriell infeksjon hos et pattedyr ved å administtere en terapeutisk effektiv mengde av en farmasøytisk sammensetning ifølge oppfirmelsen til pattedyr som ttenger det.
NO20051497A 2002-08-23 2005-03-21 Beta-laktamaseinhibitorprodrug. NO20051497D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40564002P 2002-08-23 2002-08-23
PCT/IB2003/003582 WO2004018484A1 (en) 2002-08-23 2003-08-11 Beta-lactamase inhibitor prodrug

Publications (2)

Publication Number Publication Date
NO20051497L true NO20051497L (no) 2005-03-21
NO20051497D0 NO20051497D0 (no) 2005-03-21

Family

ID=31946909

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051497A NO20051497D0 (no) 2002-08-23 2005-03-21 Beta-laktamaseinhibitorprodrug.

Country Status (31)

Country Link
US (1) US7091197B2 (no)
EP (1) EP1534717B1 (no)
JP (1) JP2005539037A (no)
KR (1) KR20050037583A (no)
CN (1) CN1688589A (no)
AP (1) AP2005003231A0 (no)
AR (1) AR041028A1 (no)
AT (1) ATE349452T1 (no)
AU (1) AU2003250489A1 (no)
BR (1) BR0313683A (no)
CA (1) CA2494953A1 (no)
DE (1) DE60310733D1 (no)
EA (1) EA007540B1 (no)
EC (1) ECSP055625A (no)
GT (1) GT200300179A (no)
HR (1) HRP20050162A2 (no)
IL (1) IL166719A0 (no)
IS (1) IS7693A (no)
MA (1) MA27387A1 (no)
MX (1) MXPA05001446A (no)
NO (1) NO20051497D0 (no)
NZ (1) NZ538340A (no)
OA (1) OA12909A (no)
PA (1) PA8579701A1 (no)
PE (1) PE20040899A1 (no)
PL (1) PL375988A1 (no)
TN (1) TNSN05054A1 (no)
TW (1) TWI250162B (no)
UY (1) UY27947A1 (no)
WO (1) WO2004018484A1 (no)
ZA (1) ZA200501513B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004108733A1 (en) * 2003-06-05 2004-12-16 Pfizer Products Inc. Beta-lactamase inhibitor prodrug
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
EP1913378A1 (de) * 2005-07-29 2008-04-23 Sigma-Aldrich Production GmbH Ionisierungsadditive enthaltende lc/ms-blends
WO2010118968A1 (en) 2009-04-16 2010-10-21 Nicox S.A. No-donor aspirin derivatives
WO2013056163A1 (en) * 2011-10-14 2013-04-18 The Regents Of The University Of California Beta-lactamase inhibitors
CN104159587A (zh) * 2012-01-06 2014-11-19 南佛罗里达大学 组合物、使用方法、以及治疗方法
CN109422765B (zh) * 2017-09-05 2020-08-28 香港理工大学深圳研究院 C类β-内酰胺酶抑制剂及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE34011B1 (en) 1969-03-13 1975-01-08 Leo Pharm Prod Ltd New penicillin esters
IE34019B1 (en) 1969-03-18 1975-01-08 Leo Pharm Prod Ltd New semi-synthetic penicillin esters
GB1267936A (en) 1969-05-28 1972-03-22 Beecham Group Ltd DERIVATIVES OF alpha-AMINOPENICILLINS
US3957764A (en) 1969-11-11 1976-05-18 Lovens Kemiske Fabrik Produktionsaktieselskab 6-aminopenicillanic acid derivatives
US3862181A (en) 1970-10-28 1975-01-21 Squibb & Sons Inc Process for preparing cephalosporins
GB1315566A (en) 1970-11-06 1973-05-02 Leo Pharm Prod Ltd Penicillanic acid derivatives
CA996929A (en) 1971-04-05 1976-09-14 Kohzi Nakano Acyloxyalkyl ester derivatives of penicillin
GB1433131A (en) 1972-03-13 1976-04-22 Astra Laekemedel Ab Penicillins
GB1426717A (en) 1972-03-13 1976-03-03 Astra Laekemedel Ab Penicillins
US4397783A (en) 1979-03-05 1983-08-09 Pfizer Inc. Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners
DE2927004A1 (de) * 1979-07-04 1981-05-27 Bayer Ag, 5090 Leverkusen Penicillansaeure-1,1-dioxide, ihre herstellung und ihre verwendung als arzneimittel als arzneimittel
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
US4432970A (en) 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use
JPS5849387A (ja) 1981-09-17 1983-03-23 Sankyo Co Ltd ７−メトキシセフアロスポリン化合物およびその製法
DE3274453D1 (en) * 1981-09-22 1987-01-15 Kureha Chemical Ind Co Ltd Penicillin derivatives
US4406887A (en) 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
US4428935A (en) * 1982-05-24 1984-01-31 Pfizer Inc. Penicillanic acid dioxide prodrug
US4521533A (en) 1984-07-12 1985-06-04 Pfizer Inc. Salts of 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide esters and beta-lactam antibiotics
DE3901405A1 (de) 1989-01-19 1990-07-26 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
JPH03206038A (ja) 1990-01-08 1991-09-09 Yoshitomi Pharmaceut Ind Ltd 抗菌剤
GB9001405D0 (en) 1990-01-22 1990-03-21 Leo Pharm Prod Ltd New intermediates,their production and use
GB9208492D0 (en) 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
WO2004108733A1 (en) 2003-06-05 2004-12-16 Pfizer Products Inc. Beta-lactamase inhibitor prodrug

Also Published As

Publication number Publication date
EA007540B1 (ru) 2006-10-27
PA8579701A1 (es) 2005-05-24
US7091197B2 (en) 2006-08-15
PL375988A1 (en) 2005-12-12
IL166719A0 (en) 2006-01-15
UY27947A1 (es) 2004-03-31
IS7693A (is) 2005-02-10
TNSN05054A1 (fr) 2007-05-14
GT200300179A (es) 2004-05-18
ECSP055625A (es) 2005-04-18
MXPA05001446A (es) 2005-06-06
US20040110740A1 (en) 2004-06-10
DE60310733D1 (de) 2007-02-08
EA200500398A1 (ru) 2005-08-25
ATE349452T1 (de) 2007-01-15
OA12909A (en) 2006-10-13
BR0313683A (pt) 2005-06-21
ZA200501513B (en) 2006-09-27
EP1534717B1 (en) 2006-12-27
AR041028A1 (es) 2005-04-27
HRP20050162A2 (en) 2005-06-30
MA27387A1 (fr) 2005-06-01
CA2494953A1 (en) 2004-03-04
NZ538340A (en) 2006-10-27
WO2004018484A1 (en) 2004-03-04
AU2003250489A1 (en) 2004-03-11
AP2005003231A0 (en) 2005-03-31
TWI250162B (en) 2006-03-01
TW200417548A (en) 2004-09-16
JP2005539037A (ja) 2005-12-22
KR20050037583A (ko) 2005-04-22
EP1534717A1 (en) 2005-06-01
NO20051497D0 (no) 2005-03-21
CN1688589A (zh) 2005-10-26
PE20040899A1 (es) 2004-12-28

Similar Documents

Publication Publication Date Title
MX2007004783A (es) Inhibidores de la proteasa del virus de la hepatitis c, y composiciones y tratamientos que los usan.
BR0115411A (pt) Combinações sinergìsticas compreendendo um inibidor de renina para doenças cardiovasculares
NO20091938L (no) 7,8-dihydro-1,6-naftyridin-5(6H)-oner og relaterte bicykliske forbindelser som inhibitorer av dipeptidyl-peptidaser IV og metoder
NO20062691L (no) Azabicykliske heterocykler som cannabinoide reseptormodulatorer
MXPA04002167A (es) Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
GEP20084439B (en) Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
WO2004062601A3 (en) Antibacterial agents
NO20073764L (no) Sammensetninger for behandling av HCV
BRPI0608436A2 (pt) derivados de n-(n-sulfonilaminometil) ciclopropanocarboxamida utilizáveis para o tratamento de dor
DE602004012269D1 (de) Quervernetzte glycopeptid-cephalosporin-antibiotika
NO20061625L (no) Behandling og/eller forhindring av urininkontinens ved bruk av prolegemidler av gaba analoger
DE602004024393D1 (de) Quervernetzte glycopeptid-cephalosporin-antibiotika
DE60208404D1 (de) Kreuzverquerte glycopeptid-cephalosporin-antibiotika
DK1132392T3 (da) Ketolid-antibiotika
NO20051497L (no) Beta-laktamaseinhibitorprodrug.
AR048336A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
NO20063483L (no) Therapeutic combinations
NO20024481L (no) Difluor smörsyre metalloproteaseinhibitorer
MXPA05012895A (es) Profarmaco inhibidor de beta-lactamasa.
CO6241136A2 (es) Formulaciones orales de liberacion controlada de compuestos moduladores de canal ionico y metodos relacionados para la prevencion de arritmias
NO20081736L (no) Antitumormidler
AU2002362008A1 (en) Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
DOP2004000918A (es) Profarmaco inhibidor de beta-lactamasa
WO2005113011A3 (en) Prodrugs of ion channel modulating compounds and uses thereof
DOP2003000686A (es) Profarmaco inhibidor de beta-lactamasa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application